OPKO Health Inc. (NASDAQ:OPK) saw a downside of -8.54% to close Monday at $1.82 after subtracting -$0.17 on the day. The 5-day average trading volume is 3,889,880 shares of the company’s common stock. It has gained $2.1750 in the past week and touched a new high 2 times within the past 5 days. An average of 3,070,380 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 4,223,614.
OPK’s 1-month performance is -11.22% or -$0.2300 on its low of $1.7000 reached on 07/28/23. The company’s shares have touched a 52-week low of $1.00 and high of $2.77, with the stock’s rally to the 52-week high happening on 07/05/23. YTD, OPK has achieved 45.60% or $0.5700 and has reached a new high 13 times. However, the current price is down -34.30% from the 52-week high price.
Valuation Metrics
OPK stock has a beta of 1.74. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.51 while the price-to-book (PB) in the most recent quarter is 0.88.
OPKO Health Inc.’s quick ratio for the period ended June 29 was 1.50, with the current ratio over the same period at 1.80. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.15, while the total debt to equity was 0.16. In terms of profitability, the gross margin trailing 12 months is 36.10%. The trailing 12-month EBITDA margin is -13.69% while for the period ending June 29, OPKO Health Inc.’s operating margin was -26.10%. The firm’s gross profit as reported stood at $288.22 million against revenue of $1.0 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -417.57% to -$19.64 million, while revenue of -$18.27 million was 6.98% off the previous quarter. Analysts expected OPK to announce -$0.07 per share in earnings in its latest quarter, but it posted -$0.03, representing a 57.10% surprise. EBITDA for the quarter stood at more than $33.87 million. OPK stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 623.55 million, with total debt at $295.67 million. Shareholders hold equity totaling $773.06 million.
Let’s look briefly at OPKO Health Inc. (OPK) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 07 August was 43.76% to suggest the stock is trending Neutral, with historical volatility in this time period at 74.06%.
The stock’s 5-day moving average is $1.8480, reflecting a -2.15% or -$0.0400 change from its current price. OPK is currently trading -13.74% above its 20-day SMA, +35.82% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +22.15% and SMA200 by+3.41%.
Stochastic %K and %D was 36.63% and 29.94% and the average true range (ATR) pointed at 0.1362. The RSI (14) points at 46.11%, while the 14-day stochastic is at 25.26% with the period’s ATR at 0.1248. The stock’s 9-day MACD Oscillator is pointing at 0.0511 and -0.0055 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for OPKO Health Inc. (NASDAQ: OPK), Barrington Research upgraded it to an Outperform rating. They previously had a Mkt perform rating on the stock. Analysts offering their rating for OPK stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate OPK as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 6 have offered a “buy” rating.
What is OPK’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $2.00 and a high of $8.50, with their median price target at $4.00. Looking at these predictions, the average price target given by analysts is for OPKO Health Inc. (OPK) stock is $4.48.
